Disorders of glucose metabolism among HIV-infected women

Andrea A. Howard, Michelle Floris-Moore, Julia H. Arnsten, Nanette Santoro, Norman Fleischer, Yungtai Lo, Ellie Schoenbaum

Research output: Contribution to journalArticle

62 Citations (Scopus)

Abstract

Background. Abnormal glucose metabolism in HIV-infected patients has largely been attributed to the use of protease inhibitors. However, most studies of glucose metabolism in HIV-infected patients have focused on men or have lacked appropriate control groups. Methods. We assessed the factors associated with previously diagnosed diabetes among 620 middle-aged women with or at risk for HIV infection. For a subset of 221 women without previously diagnosed diabetes, we performed an oral glucose tolerance test (OGTT) to measure glucose and insulin levels, and we assessed factors associated with abnormal glucose tolerance, insulin resistance, and insulin secretion. Results. Thirteen percent of the women in the present study had previously diagnosed diabetes. Among women without previously diagnosed diabetes who underwent an OGTT, 6% had previously undiagnosed diabetes, and 12% had impaired glucose tolerance (IGT). According to multivariate analysis, factors that were associated with previously diagnosed diabetes included current methadone treatment, body mass index of ≥25, family history of diabetes, and physical inactivity. Factors that were independently associated with an abnormal result of an OGTT (i.e., a result consistent with IGT or diabetes) included age ≥50 years, family history of diabetes, physical inactivity, and a high number of pack-years of smoking. Factors independently associated with insulin resistance included waist circumference, Hispanic ethnicity, physical inactivity, and, among HIV-infected women, use of HAART that did not include protease inhibitors. Factors associated with lower levels of insulin secretion included current opiate use (i.e., methadone or heroin) and older age. Conclusions. Abnormal glucose metabolism is highly prevalent among middle-aged women with or at risk for HIV infection, particularly women who use opiates. Screening for diabetes in the HIV primary care setting should occur for women who have classic risk factors for diabetes, rather than solely for women who are taking PIs. Interventions that target modifiable risk factors, including obesity and physical inactivity, are also warranted.

Original languageEnglish (US)
Pages (from-to)1492-1499
Number of pages8
JournalClinical Infectious Diseases
Volume40
Issue number10
DOIs
StatePublished - May 15 2005

Fingerprint

Glucose Metabolism Disorders
HIV
Opiate Alkaloids
Glucose
Glucose Tolerance Test
Glucose Intolerance
Methadone
Insulin
Protease Inhibitors
HIV Infections
Insulin Resistance
Heroin
Highly Active Antiretroviral Therapy
Waist Circumference
Hispanic Americans
Primary Health Care
Body Mass Index
Multivariate Analysis
Obesity
Smoking

ASJC Scopus subject areas

  • Immunology

Cite this

Disorders of glucose metabolism among HIV-infected women. / Howard, Andrea A.; Floris-Moore, Michelle; Arnsten, Julia H.; Santoro, Nanette; Fleischer, Norman; Lo, Yungtai; Schoenbaum, Ellie.

In: Clinical Infectious Diseases, Vol. 40, No. 10, 15.05.2005, p. 1492-1499.

Research output: Contribution to journalArticle

Howard AA, Floris-Moore M, Arnsten JH, Santoro N, Fleischer N, Lo Y et al. Disorders of glucose metabolism among HIV-infected women. Clinical Infectious Diseases. 2005 May 15;40(10):1492-1499. https://doi.org/10.1086/429824
Howard, Andrea A. ; Floris-Moore, Michelle ; Arnsten, Julia H. ; Santoro, Nanette ; Fleischer, Norman ; Lo, Yungtai ; Schoenbaum, Ellie. / Disorders of glucose metabolism among HIV-infected women. In: Clinical Infectious Diseases. 2005 ; Vol. 40, No. 10. pp. 1492-1499.
@article{07bf3bc9e62b4c12a32e36d22d205575,
title = "Disorders of glucose metabolism among HIV-infected women",
abstract = "Background. Abnormal glucose metabolism in HIV-infected patients has largely been attributed to the use of protease inhibitors. However, most studies of glucose metabolism in HIV-infected patients have focused on men or have lacked appropriate control groups. Methods. We assessed the factors associated with previously diagnosed diabetes among 620 middle-aged women with or at risk for HIV infection. For a subset of 221 women without previously diagnosed diabetes, we performed an oral glucose tolerance test (OGTT) to measure glucose and insulin levels, and we assessed factors associated with abnormal glucose tolerance, insulin resistance, and insulin secretion. Results. Thirteen percent of the women in the present study had previously diagnosed diabetes. Among women without previously diagnosed diabetes who underwent an OGTT, 6{\%} had previously undiagnosed diabetes, and 12{\%} had impaired glucose tolerance (IGT). According to multivariate analysis, factors that were associated with previously diagnosed diabetes included current methadone treatment, body mass index of ≥25, family history of diabetes, and physical inactivity. Factors that were independently associated with an abnormal result of an OGTT (i.e., a result consistent with IGT or diabetes) included age ≥50 years, family history of diabetes, physical inactivity, and a high number of pack-years of smoking. Factors independently associated with insulin resistance included waist circumference, Hispanic ethnicity, physical inactivity, and, among HIV-infected women, use of HAART that did not include protease inhibitors. Factors associated with lower levels of insulin secretion included current opiate use (i.e., methadone or heroin) and older age. Conclusions. Abnormal glucose metabolism is highly prevalent among middle-aged women with or at risk for HIV infection, particularly women who use opiates. Screening for diabetes in the HIV primary care setting should occur for women who have classic risk factors for diabetes, rather than solely for women who are taking PIs. Interventions that target modifiable risk factors, including obesity and physical inactivity, are also warranted.",
author = "Howard, {Andrea A.} and Michelle Floris-Moore and Arnsten, {Julia H.} and Nanette Santoro and Norman Fleischer and Yungtai Lo and Ellie Schoenbaum",
year = "2005",
month = "5",
day = "15",
doi = "10.1086/429824",
language = "English (US)",
volume = "40",
pages = "1492--1499",
journal = "Clinical Infectious Diseases",
issn = "1058-4838",
publisher = "Oxford University Press",
number = "10",

}

TY - JOUR

T1 - Disorders of glucose metabolism among HIV-infected women

AU - Howard, Andrea A.

AU - Floris-Moore, Michelle

AU - Arnsten, Julia H.

AU - Santoro, Nanette

AU - Fleischer, Norman

AU - Lo, Yungtai

AU - Schoenbaum, Ellie

PY - 2005/5/15

Y1 - 2005/5/15

N2 - Background. Abnormal glucose metabolism in HIV-infected patients has largely been attributed to the use of protease inhibitors. However, most studies of glucose metabolism in HIV-infected patients have focused on men or have lacked appropriate control groups. Methods. We assessed the factors associated with previously diagnosed diabetes among 620 middle-aged women with or at risk for HIV infection. For a subset of 221 women without previously diagnosed diabetes, we performed an oral glucose tolerance test (OGTT) to measure glucose and insulin levels, and we assessed factors associated with abnormal glucose tolerance, insulin resistance, and insulin secretion. Results. Thirteen percent of the women in the present study had previously diagnosed diabetes. Among women without previously diagnosed diabetes who underwent an OGTT, 6% had previously undiagnosed diabetes, and 12% had impaired glucose tolerance (IGT). According to multivariate analysis, factors that were associated with previously diagnosed diabetes included current methadone treatment, body mass index of ≥25, family history of diabetes, and physical inactivity. Factors that were independently associated with an abnormal result of an OGTT (i.e., a result consistent with IGT or diabetes) included age ≥50 years, family history of diabetes, physical inactivity, and a high number of pack-years of smoking. Factors independently associated with insulin resistance included waist circumference, Hispanic ethnicity, physical inactivity, and, among HIV-infected women, use of HAART that did not include protease inhibitors. Factors associated with lower levels of insulin secretion included current opiate use (i.e., methadone or heroin) and older age. Conclusions. Abnormal glucose metabolism is highly prevalent among middle-aged women with or at risk for HIV infection, particularly women who use opiates. Screening for diabetes in the HIV primary care setting should occur for women who have classic risk factors for diabetes, rather than solely for women who are taking PIs. Interventions that target modifiable risk factors, including obesity and physical inactivity, are also warranted.

AB - Background. Abnormal glucose metabolism in HIV-infected patients has largely been attributed to the use of protease inhibitors. However, most studies of glucose metabolism in HIV-infected patients have focused on men or have lacked appropriate control groups. Methods. We assessed the factors associated with previously diagnosed diabetes among 620 middle-aged women with or at risk for HIV infection. For a subset of 221 women without previously diagnosed diabetes, we performed an oral glucose tolerance test (OGTT) to measure glucose and insulin levels, and we assessed factors associated with abnormal glucose tolerance, insulin resistance, and insulin secretion. Results. Thirteen percent of the women in the present study had previously diagnosed diabetes. Among women without previously diagnosed diabetes who underwent an OGTT, 6% had previously undiagnosed diabetes, and 12% had impaired glucose tolerance (IGT). According to multivariate analysis, factors that were associated with previously diagnosed diabetes included current methadone treatment, body mass index of ≥25, family history of diabetes, and physical inactivity. Factors that were independently associated with an abnormal result of an OGTT (i.e., a result consistent with IGT or diabetes) included age ≥50 years, family history of diabetes, physical inactivity, and a high number of pack-years of smoking. Factors independently associated with insulin resistance included waist circumference, Hispanic ethnicity, physical inactivity, and, among HIV-infected women, use of HAART that did not include protease inhibitors. Factors associated with lower levels of insulin secretion included current opiate use (i.e., methadone or heroin) and older age. Conclusions. Abnormal glucose metabolism is highly prevalent among middle-aged women with or at risk for HIV infection, particularly women who use opiates. Screening for diabetes in the HIV primary care setting should occur for women who have classic risk factors for diabetes, rather than solely for women who are taking PIs. Interventions that target modifiable risk factors, including obesity and physical inactivity, are also warranted.

UR - http://www.scopus.com/inward/record.url?scp=18244391191&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=18244391191&partnerID=8YFLogxK

U2 - 10.1086/429824

DO - 10.1086/429824

M3 - Article

C2 - 15844072

AN - SCOPUS:18244391191

VL - 40

SP - 1492

EP - 1499

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

SN - 1058-4838

IS - 10

ER -